Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

TCC 1

Interventions

Saline Solution, Hypertonic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × TCC × Saline Solution, Hypertonic × Clear all
NCT04671407 2021-02-18

The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer

Kaplan Medical Center

Phase 2 Unknown
150 enrolled

TCC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡